Cancer BiologyCancer ResearchPeer-reviewed
ETS1 Orchestrates a Hybrid EMT Program Driving in vivo Metastasis and Immune Evasion
Benjamin Ziman, Talia A. Wenger, Chehyun Nam…·De‐Chen Lin
This study identifies ETS1 as a master regulator of a hybrid EMT program in UASCC that drives metastasis and immune evasion, and shows HSP90 inhibitors can target ETS1-driven tumors.